HÄMOGLOBINZUSAMMENSETZUNGEN

Patent europeic · EP2440239 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2440239
Numer da la dumonda
EP10727289
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
09-06-2010
Publitgà
18-04-2012
Concedì
13-09-2017
Stritgà
30-06-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 9/08 (2006.01)
A61K 38/42 (2006.01)
A61K 47/18 (2017.01)
Prioritad
US 185547 P 09.06.2009
Dumonda PCT
PCT/US2010/038046 09.06.2010
Publicaziun PCT
WO2010/144629 16.12.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-01-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.01.2021

  2. 21-11-2017

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 21.11.2017

  3. 13-09-2017

    Concedì

    Published in Swissreg on 13.09.2017

Partidas

Possessur

Prolong Pharmaceuticals, LLC

300 Corporate Court Suite B, South Plainfield, NJ 07080, US

Represchentant

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventur

ABUCHOWSKI, Abraham

Califon NJ 07830, US

SLOSHBERG, Steven

Union NJ 07083, US

O'HARE, Keith

East Windsor NJ 08520, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.